NCT02109029View on ClinicalTrials.gov

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin Peglispro

Administered IV

DRUG

Human Insulin

Administered IV

Trial Locations (1)

8036

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Graz

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02109029 - A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue | Biotech Hunter | Biotech Hunter